BEAM
Price
$29.01
Change
+$2.16 (+8.04%)
Updated
Dec 20 closing price
72 days until earnings call
CRSP
Price
$40.72
Change
+$0.34 (+0.84%)
Updated
Dec 20 closing price
58 days until earnings call
Ad is loading...

BEAM vs CRSP

Header iconBEAM vs CRSP Comparison
Open Charts BEAM vs CRSPBanner chart's image
Beam Therapeutics
Price$29.01
Change+$2.16 (+8.04%)
Volume$2.74M
CapitalizationN/A
CRISPR Therapeutics AG
Price$40.72
Change+$0.34 (+0.84%)
Volume$3.35M
CapitalizationN/A
BEAM vs CRSP Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CRSP commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRSP is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (BEAM: $29.01 vs. CRSP: $40.72)
Brand notoriety: BEAM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 220% vs. CRSP: 188%
Market capitalization -- BEAM: $2.4B vs. CRSP: $3.48B
BEAM [@Biotechnology] is valued at $2.4B. CRSP’s [@Biotechnology] market capitalization is $3.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 4 bearish.
  • CRSP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CRSP.

Price Growth

BEAM (@Biotechnology) experienced а +3.87% price change this week, while CRSP (@Biotechnology) price change was -6.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

CRSP is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.48B) has a higher market cap than BEAM($2.41B). BEAM YTD gains are higher at: 6.576 vs. CRSP (-34.952). BEAM has higher annual earnings (EBITDA): -160.83M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. BEAM (926M). BEAM has less debt than CRSP: BEAM (162M) vs CRSP (228M). BEAM has higher revenues than CRSP: BEAM (350M) vs CRSP (200M).
BEAMCRSPBEAM / CRSP
Capitalization2.41B3.48B69%
EBITDA-160.83M-313.08M51%
Gain YTD6.576-34.952-19%
P/E RatioN/AN/A-
Revenue350M200M175%
Total Cash926M1.94B48%
Total Debt162M228M71%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRSP
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAMVX11.680.14
+1.21%
Virtus Ceredex Mid-Cap Value Equity A
ICTVX9.150.10
+1.10%
ICON Utilities and Income Inv
FCUDX19.200.17
+0.89%
NYLI PineStone U.S. Equity Class R6
FAASX28.600.14
+0.49%
Fidelity Advisor Asset Manager 70% A
ELDFX21.550.10
+0.47%
Elfun Diversified